243 related articles for article (PubMed ID: 9289838)
1. [Orthotopic liver transplantation for familial Portuguese amyloidosis].
Fournier B; Giostra E; Mentha G; Huber O; Hadengue A; Morel P
Schweiz Med Wochenschr Suppl; 1997; 89():36S-40S. PubMed ID: 9289838
[TBL] [Abstract][Full Text] [Related]
2. [Familial amyloid neuropathies].
Julien J
Rev Neurol (Paris); 1993; 149(10):517-23. PubMed ID: 8023063
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for familial amyloid polyneuropathy.
Monteiro E; Perdigoto R; Furtado AL
Hepatogastroenterology; 1998; 45(23):1375-80. PubMed ID: 9840068
[TBL] [Abstract][Full Text] [Related]
4. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
García-Herola A; Prieto M; Pascual S; Berenguer M; López-Viedma B; Mir J; Vilchez JJ; Berenguer J
Liver Transpl Surg; 1999 May; 5(3):246-8. PubMed ID: 10226117
[TBL] [Abstract][Full Text] [Related]
5. Outcome of liver transplantation for familial amyloidotic polyneuropathy.
Sharma P; Perri RE; Sirven JE; Zeldenrust SR; Brandhagen DJ; Rosen CB; Douglas DD; Mulligan DC; Rakela J; Wiesner RH; Balan V
Liver Transpl; 2003 Dec; 9(12):1273-80. PubMed ID: 14625827
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Lewis WD; Skinner M; Simms RW; Jones LA; Cohen AS; Jenkins RL
Clin Transplant; 1994 Apr; 8(2 Pt 1):107-10. PubMed ID: 8019018
[TBL] [Abstract][Full Text] [Related]
7. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
Ando Y
Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
[TBL] [Abstract][Full Text] [Related]
8. [Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation].
Ikeda S; Yanagisawa N
Rinsho Shinkeigaku; 1995 Dec; 35(12):1433-5. PubMed ID: 8752421
[TBL] [Abstract][Full Text] [Related]
9. The molecular biology and clinical features of amyloid neuropathy.
Benson MD; Kincaid JC
Muscle Nerve; 2007 Oct; 36(4):411-23. PubMed ID: 17554795
[TBL] [Abstract][Full Text] [Related]
10. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
11. [Genetic analysis and a new therapy for a hereditary disease: familial amyloid polyneuropathy].
Furihata K
Rinsho Byori; 1994 Nov; 42(11):1137-43. PubMed ID: 7844885
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients.
Suhr OB; Holmgren G; Steen L; Wikström L; Norden G; Friman S; Duraj FF; Groth CG; Ericzon BG
Transplantation; 1995 Nov; 60(9):933-8. PubMed ID: 7491696
[TBL] [Abstract][Full Text] [Related]
13. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
14. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
15. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation.
Snanoudj R; Durrbach A; Gauthier E; Adams D; Samuel D; Ferlicot S; Bedossa P; Prigent A; Bismuth H; Charpentier B
Nephrol Dial Transplant; 2004 Jul; 19(7):1779-85. PubMed ID: 15150345
[TBL] [Abstract][Full Text] [Related]
16. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
Lobato L
J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
[TBL] [Abstract][Full Text] [Related]
17. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
18. Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
Rocha A; Lobato L; Silva H; Beirão I; Santos J; Pessegueiro H; Almeida R; Cabrita A
Transplant Proc; 2011; 43(1):189-93. PubMed ID: 21335185
[TBL] [Abstract][Full Text] [Related]
19. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.
Bittencourt PL; Couto CA; Farias AQ; Marchiori P; Bosco Massarollo PC; Mies S
Liver Transpl; 2002 Jan; 8(1):34-9. PubMed ID: 11799483
[TBL] [Abstract][Full Text] [Related]
20. New transthyretin variants SER 91 and SER 116 associated with familial amyloidotic polyneuropathy. Mutations in brief no. 151. Online.
Misrahi AM; Plante V; Lalu T; Serre L; Adams D; Lacroix DC; Saïd G
Hum Mutat; 1998; 12(1):71. PubMed ID: 10627135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
